The Pan American Health Organization issued an epidemiological alert on the potential spread on the continent of the mosquito-borne viral disease Zika, which is similar to dengue and Chikungunya, but with milder symptoms.
The vaccine proved effective against dengue symptoms in 56.5 percent of those studied and even more effective against the hemorrhagic fever, at 88.5 percent.
